TY - JOUR
T1 - Activation of dual apoptotic pathways in human melanocytes and protection by survivin
AU - Liu, Tong
AU - Biddle, Diana
AU - Hanks, Adrianne N.
AU - Brouha, Brook
AU - Yan, Hui
AU - Lee, Ray M.
AU - Leachman, Sancy A.
AU - Grossman, Douglas
N1 - Funding Information:
We thank Dr Dario Altieri for the GFP- and Survivin-expressing adenoviruses, Don Gentry in our core facility for help with fluorescence microscopy, and Ken Boucher for discussions on statistical analysis. This work was supported by NIH Grant AR050102 (DG), and the Huntsman Cancer Foundation (DG, RML, SAL).
PY - 2006/10/30
Y1 - 2006/10/30
N2 - Apoptosis resistance in melanoma is a primary cause of treatment failure. Apoptotic pathways in melanocytes, from which melanoma arises, are poorly characterized. Human melanocytes were susceptible to apoptosis following exposure to UV radiation (UVB, 24-48 hours), 4-tert-butylphenol (4-TBP, 1-4 hours), and cisplatin (24-48 hours). These responses were associated with Bid cleavage, caspase activation (caspases 3, 8, and 9), mitochondrial depolarization and release of cytochrome c, Smac/DIABLO, and apoptosis-inducing factor (AIF), but not endonuclease G. The apoptotic responses and AIF release were caspase-independent, as they were not blocked by zVal-Ala-Asp(OMe)- fluoromethyl ketone (zVAD-fmk). While RNA interference-mediated knockdown of AIF protected melanocytes against apoptosis induced by serum withdrawal, apoptotic responses to UVB, cisplatin, and 4-TBP were not compromised by AIF knockdown, even in the presence of zVAD-fmk. Finally, adenoviral-mediated expression of Survivin, an inhibitor of apoptosis expressed in melanoma but not melanocytes, protected melanocytes against UVB-induced apoptosis. Survivin expression in melanocytes partially blocked caspase activation and release of mitochondrial release of AIF, cytochrome c, and Smac induced by UVB. These data indicate that multiple stimuli can activate both caspase-dependent and caspase-independent apoptotic pathways in melanocytes, and that endogenous expression of Survivin in melanoma may contribute to apoptosis resistance by multiple mechanisms.
AB - Apoptosis resistance in melanoma is a primary cause of treatment failure. Apoptotic pathways in melanocytes, from which melanoma arises, are poorly characterized. Human melanocytes were susceptible to apoptosis following exposure to UV radiation (UVB, 24-48 hours), 4-tert-butylphenol (4-TBP, 1-4 hours), and cisplatin (24-48 hours). These responses were associated with Bid cleavage, caspase activation (caspases 3, 8, and 9), mitochondrial depolarization and release of cytochrome c, Smac/DIABLO, and apoptosis-inducing factor (AIF), but not endonuclease G. The apoptotic responses and AIF release were caspase-independent, as they were not blocked by zVal-Ala-Asp(OMe)- fluoromethyl ketone (zVAD-fmk). While RNA interference-mediated knockdown of AIF protected melanocytes against apoptosis induced by serum withdrawal, apoptotic responses to UVB, cisplatin, and 4-TBP were not compromised by AIF knockdown, even in the presence of zVAD-fmk. Finally, adenoviral-mediated expression of Survivin, an inhibitor of apoptosis expressed in melanoma but not melanocytes, protected melanocytes against UVB-induced apoptosis. Survivin expression in melanocytes partially blocked caspase activation and release of mitochondrial release of AIF, cytochrome c, and Smac induced by UVB. These data indicate that multiple stimuli can activate both caspase-dependent and caspase-independent apoptotic pathways in melanocytes, and that endogenous expression of Survivin in melanoma may contribute to apoptosis resistance by multiple mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=33748767375&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748767375&partnerID=8YFLogxK
U2 - 10.1038/sj.jid.5700381
DO - 10.1038/sj.jid.5700381
M3 - Article
C2 - 16728972
AN - SCOPUS:33748767375
SN - 0022-202X
VL - 126
SP - 2247
EP - 2256
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 10
ER -